TRAMETINIB Drug Patent Profile
✉ Email this page to a colleague
When do Trametinib patents expire, and what generic alternatives are available?
Trametinib is a drug marketed by Novugen and is included in one NDA.
The generic ingredient in TRAMETINIB is trametinib dimethyl sulfoxide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the trametinib dimethyl sulfoxide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRAMETINIB?
- What are the global sales for TRAMETINIB?
- What is Average Wholesale Price for TRAMETINIB?
Summary for TRAMETINIB
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | TRAMETINIB at DailyMed |
US Patents and Regulatory Information for TRAMETINIB
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novugen | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-001 | Aug 6, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Novugen | TRAMETINIB DIMETHYL SULFOXIDE | trametinib dimethyl sulfoxide | TABLET;ORAL | 219002-002 | Aug 6, 2024 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
